Maarten Ooms

719 total citations
32 papers, 457 citations indexed

About

Maarten Ooms is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maarten Ooms has authored 32 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maarten Ooms's work include Radiopharmaceutical Chemistry and Applications (18 papers), Medical Imaging Techniques and Applications (9 papers) and Phosphodiesterase function and regulation (9 papers). Maarten Ooms is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (18 papers), Medical Imaging Techniques and Applications (9 papers) and Phosphodiesterase function and regulation (9 papers). Maarten Ooms collaborates with scholars based in Belgium, Canada and United States. Maarten Ooms's co-authors include Guy Bormans, Thomas Cardinaels, Frederik Cleeren, Andrew R. Burgoyne, Christophe M. Deroose, Koen Van Laere, Alfons Verbruggen, Michel Koole, Michiel Van de Voorde and Sofie Celen and has published in prestigious journals such as NeuroImage, Journal of Neurochemistry and Inorganic Chemistry.

In The Last Decade

Maarten Ooms

30 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maarten Ooms Belgium 14 275 117 108 86 61 32 457
Nicole Bausbacher Germany 12 230 0.8× 77 0.7× 106 1.0× 102 1.2× 29 0.5× 31 406
Yoshiro Ohmomo Japan 14 312 1.1× 151 1.3× 121 1.1× 84 1.0× 31 0.5× 52 540
Véronique Dumulon‐Perreault Canada 11 257 0.9× 108 0.9× 139 1.3× 89 1.0× 19 0.3× 24 411
Kohshin Washiyama Japan 16 355 1.3× 92 0.8× 134 1.2× 146 1.7× 9 0.1× 51 570
Mareike Roscher Germany 14 235 0.9× 150 1.3× 129 1.2× 169 2.0× 9 0.1× 28 596
Bradford D. Henderson United States 12 267 1.0× 99 0.8× 68 0.6× 67 0.8× 11 0.2× 23 463
Ganghua Tang China 12 275 1.0× 108 0.9× 167 1.5× 55 0.6× 15 0.2× 54 548
Michał Maurin Poland 11 145 0.5× 61 0.5× 88 0.8× 82 1.0× 60 1.0× 31 436
Roberta Carbonara Italy 14 97 0.4× 137 1.2× 58 0.5× 82 1.0× 9 0.1× 32 397
Marcel Cleij United Kingdom 12 304 1.1× 190 1.6× 85 0.8× 93 1.1× 13 0.2× 17 712

Countries citing papers authored by Maarten Ooms

Since Specialization
Citations

This map shows the geographic impact of Maarten Ooms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten Ooms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten Ooms more than expected).

Fields of papers citing papers by Maarten Ooms

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten Ooms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten Ooms. The network helps show where Maarten Ooms may publish in the future.

Co-authorship network of co-authors of Maarten Ooms

This figure shows the co-authorship network connecting the top 25 collaborators of Maarten Ooms. A scholar is included among the top collaborators of Maarten Ooms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten Ooms. Maarten Ooms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wellens, Jasmien, et al.. (2025). Cysteine-selective [188Re]Re(v) radiolabelling of a Nanobody® for targeted radionuclide therapy using a “chelate-then-click” approach. Chemical Science. 16(14). 6089–6098. 1 indexed citations
2.
Fernandes, Célia, Paula Raposinho, Ana Belchior, et al.. (2025). Mitochondria-tropic radioconjugates to enhance the therapeutic potential of terbium-161. EJNMMI Radiopharmacy and Chemistry. 10(1). 18–18.
3.
Voorde, Michiel Van de, Maarten Ooms, Sathiya Sekar, et al.. (2024). Quantitative SPECT imaging of 155Tb and 161Tb for preclinical theranostic radiopharmaceutical development. EJNMMI Physics. 11(1). 77–77. 6 indexed citations
4.
Crabbé, Melissa, et al.. (2024). Targeted radiopharmaceuticals: an underexplored strategy for ovarian cancer. Theranostics. 14(16). 6281–6300. 1 indexed citations
5.
Koole, Michel, Christophe M. Deroose, Michiel Van de Voorde, et al.. (2024). Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside. Theranostics. 14(4). 1720–1743. 19 indexed citations
6.
Zhang, Chengcheng, Michiel Van de Voorde, Jutta Zeisler, et al.. (2024). Preclinical evaluation of MC1R targeting theranostic pair [155Tb]Tb-crown-αMSH and [161Tb]Tb-crown-αMSH. Nuclear Medicine and Biology. 136-137. 108925–108925. 4 indexed citations
7.
Cawthorne, Christopher, Christophe M. Deroose, Thomas Cardinaels, et al.. (2023). Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist. Nuclear Medicine and Biology. 118-119. 108338–108338. 7 indexed citations
8.
Merkens, Helen, Zheliang Yuan, Michiel Van de Voorde, et al.. (2023). Preclinical Evaluation of [155/161Tb]Tb-Crown-TATE—A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours. Molecules. 28(7). 3155–3155. 16 indexed citations
9.
Li, Cen, Yang Gao, Michiel Van de Voorde, et al.. (2023). Comparative Study of a Decadentate Acyclic Chelate, HOPO-O10, and Its Octadentate Analogue, HOPO-O8, for Radiopharmaceutical Applications. Inorganic Chemistry. 62(50). 20549–20566. 8 indexed citations
10.
Deroose, Christophe M., Thomas Cardinaels, Andrew R. Burgoyne, et al.. (2021). Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside. Pharmaceutics. 13(5). 599–599. 69 indexed citations
11.
Voorde, Michiel Van de, Charlotte Duchemin, Reinhard Heinke, et al.. (2021). Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy. Frontiers in Medicine. 8. 675221–675221. 13 indexed citations
12.
Laat, Bart de, Maarten Ooms, Jacob M. Hooker, et al.. (2021). Effects of chronic voluntary alcohol consumption on PDE10A availability: a longitudinal behavioral and [18F]JNJ42259152 PET study in rats. European Journal of Nuclear Medicine and Molecular Imaging. 49(2). 492–502. 1 indexed citations
13.
Dekempeneer, Yana, Vicky Caveliers, Maarten Ooms, et al.. (2020). Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer. Molecular Pharmaceutics. 17(9). 3553–3566. 45 indexed citations
14.
Ahamed, Muneer, Maarten Ooms, Philippe Berben, et al.. (2017). Synthesis and preclinical evaluation of [ 11 C]MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL). European Journal of Medicinal Chemistry. 136. 104–113. 17 indexed citations
15.
Ooms, Maarten, Sofie Celen, Ronald De Hoogt, et al.. (2016). Striatal phosphodiesterase 10A availability is altered secondary to chronic changes in dopamine neurotransmission. EJNMMI Radiopharmacy and Chemistry. 1(1). 3–3. 11 indexed citations
16.
Ory, Dieter, Tjibbe de Groot, Kim Serdons, et al.. (2015). Retention of [18F]fluoride on reversed phase HPLC columns. Journal of Pharmaceutical and Biomedical Analysis. 111. 209–214. 45 indexed citations
17.
Ooms, Maarten, Sofie Celen, Michel Koole, et al.. (2014). Synthesis and biological evaluation of carbon-11 and fluorine-18 labeled tracers for in vivo visualization of PDE10A. Nuclear Medicine and Biology. 41(8). 695–704. 13 indexed citations
18.
Ooms, Maarten, Janaki Raman Rangarajan, Kathleen Vunckx, et al.. (2014). Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice. Neurobiology of Aging. 35(12). 2858–2869. 25 indexed citations
19.
Celen, Sofie, Michel Koole, Maarten Ooms, et al.. (2013). Preclinical evaluation of [18F]JNJ42259152 as a PET tracer for PDE10A. NeuroImage. 82. 13–22. 30 indexed citations
20.
Ooms, Maarten, Sofie Celen, Alfons Verbruggen, Koen Van Laere, & Guy Bormans. (2011). Comparison of [C-11]-MP10, [C-11]-isoMP10 and [F-18]-isoJNJ41510417 as potential radioligands for positron emission tomography imaging of phosphodiesterase-10A in the brain. Journal of Labelled Compounds and Radiopharmaceuticals. 54. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole Bausbacher Breakdown of academic impact, for papers by Yoshiro Ohmomo Breakdown of academic impact, for papers by Véronique Dumulon‐Perreault Breakdown of academic impact, for papers by Kohshin Washiyama Breakdown of academic impact, for papers by Mareike Roscher Breakdown of academic impact, for papers by Bradford D. Henderson Breakdown of academic impact, for papers by Ganghua Tang Breakdown of academic impact, for papers by Michał Maurin Breakdown of academic impact, for papers by Roberta Carbonara Breakdown of academic impact, for papers by Marcel Cleij
Rankless by CCL
2026